Pmv Pharmaceuticals, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
SCHEDULE: OrbiMed Exits PMV Pharma Stake
OrbiMed Advisors and OrbiMed Capital GP V LLC have ceased to be beneficial owners of more than 5% of PMV Pharmaceuticals, Inc. common stock after significant share sales.
NASDAQ
SCHEDULE: OrbiMed Reduces PMV Pharma Stake to 9.4%
OrbiMed Advisors and OrbiMed Capital GP V have reduced their beneficial ownership in PMV Pharmaceuticals, Inc. to 9.4% through recent share sales.